Sunovion Pharmaceuticals on Monday announced that Aptiom (eslicarbazepine acetate), a once-daily antiepileptic drug, is now available across the United States.
The Food and Drug Administration has approved a new drug for treating epileptic seizures, the agency said Friday.
A federal appellate court has ruled in favor of Mylan in a case involving a drug for chronic obstructive pulmonary disease, the drug maker said.
Prasco Labs is distributing an authorized generic version of a respiratory drug under an agreement with the branded drug's manufacturer.
A unit of generic drug maker Mylan has settled with Sunovion Pharmaceuticals over a drug used to treat chronic obstructive pulmonary disease and asthma.
Generic drug maker Mylan plans to challenge a court decision that requires it to pay almost $20 million to a drug company whose product it tried to market as a generic.
The Pharmaceutical Research and Manufacturers of America has added four new members to its board.